The prolactin (PRL) receptor is a member of the family of cytokine receptors that lack Intrinsic tyrosine kinase activity but contain two conserved cysteines in their (IL)-3 , IL-4, IL-5, IL-6, IL-10, granulocyte-macrophage colony-stimulating factor, epidermal growth factor (EGF), platelet-derived growth factor, ciliary neurotrophic factor, growth hormone, and erythropoietin (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Because PRL treatment of cells induces the tyrosine phosphorylation of several cellular proteins (3, 4) and also rapidly activates the expression of the IFN regulatory factor 1 (IRF-1) gene (20) 
Prolactin (PRL) is a pituitary hormone responsible for numerous biological effects including regulation of reproduction and lactation, maintenance of salt and water balance, and modulation of growth, differentiation, and immune function (1) . The receptors for PRL belong to a family of cytokine receptors that also includes receptors for the interferons (IFNs) (1, 2) . Two forms of the PRL receptor have been characterized in mammalian cells and have been found to differ in their cytoplasmic domains (1) . Neither form of the receptor contains a tyrosine kinase domain. Although the signal transduction mechanism of PRL remains unclear, several recent reports indicate (3, 4) that a defined set of cellular proteins is rapidly tyrosine-phosphorylated upon exposure ofrat Nb2 lymphoma cells to PRL, and one ofthese phosphotyrosyl proteins copurifies with the activated PRL receptor (4) . Another report indicates that several inhibitors of tyrosine kinase activity prevent PRL-induced expression of the milk protein genes (5) .
Both IFN-a and IFN-y regulate gene expression by activation of tyrosine kinase(s) that phosphorylate a 91-kDa transcription factor, p91. This SH2 domain-containing protein then translocates to the nucleus where it is a component of several multisubunit complexes that bind enhancers required for the transcriptional activation of specific cellular genes (6) (7) (8) . For several cytokines, a common pathway exists that results in activated gene expression and tyrosine phosphorylation of cellular proteins that function as positive transcriptional regulators. These cytokines include among others interleukin (IL)-3, IL-4, IL-5, IL-6, IL-10, granulocyte-macrophage colony-stimulating factor, epidermal growth factor (EGF), platelet-derived growth factor, ciliary neurotrophic factor, growth hormone, and erythropoietin (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Because PRL treatment of cells induces the tyrosine phosphorylation of several cellular proteins (3, 4) and also rapidly activates the expression of the IFN regulatory factor 1 (IRF-1) gene (20) The suspension was homogenized in a Dounce homogenizer and centrifuged at 3000 x g for 10 min at 4TC. The nuclear pellet was resuspended in buffer A with 0.3 M NaCl, extracted by vortex mixing, and centrifuged at 3000 x g for 10 min. The supernatant (nuclear extract) was transferred to a new tube. Protein concentrations for each extract were determined and normalized by the addition of extraction buffer (9) .
Electrophoretic Mobility Shift Assay (EMSA). EMSAs were performed as described (21) . The IFN-y-induced element (5'-AGCCTGATTTCCCCGAAATGATGAGGCCGAGT-GG-3') of the mouse IRF-1 gene (IRF-1E) (22) The samples were then analyzed by SDS/PAGE on 8% gels followed by electrophoretic transfer to Immobilon-P membranes (Millipore) by using a semi-dry transfer apparatus (Bio-Rad). The membranes were then blocked using 4% (wt/vol) ovalbumin (Sigma) in Tris-buffered saline (150 mM NaCl/10 mM Tris, pH 8.0) with 0.05% Tween 20 for 1 hr at room temperature followed by incubation with biotinconjugated mouse anti-phosphotyrosine monoclonal antibody (PY20) (ICN) for at least 2 hr at room temperature. After extensive washing, the membranes were incubated with peroxidase-conjugated streptavidin (Sigma) and developed using enhanced chemiluminescence (Amersham). To analyze those protein(s) specifically immunoprecipitated after chemiluminescence detection of the bound mouse antiphosphotyrosine antibody, we reexposed the membranes to anti-Jakl or anti-Jak2 serum for 2-24 hr at room temperature. After washing, the membranes were probed with alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin and developed using nitroblue tetrazolium.
RESULTS AND DISCUSSION
An enhancer sequence that we have designated IRF-1E has been defined in the promoter of the IRF-1 gene that is required for IFN-y to induce its expression (22, 26, 27) . Similar sequences, required for IFN-y induction, have been identified in the promoters of the FcyRI, ICSBP, guanylate binding protein, and Ly-6A/E genes. These sequences also have been shown to bind tyrosine-phosphorylated p91 after treatment of cells with IFN-,y (21, (25) (26) (27) (28) . To determine whether the IRF-1E also interacted with specific proteins activated in response to PRL, we prepared nuclear extracts from Nb2 cells that had been incubated with PRL for 5, 15, 30, or 60 min and performed EMSAs with a 32P-labeled oligonucleotide probe corresponding to the IRF-1E (Fig. 1A) .
A PRL-stimulated factor (PRLSF) was detected in nuclear extracts from cells after a 5-min incubation with PRL (lanes 1 vs. 2) and was still present in cells after 1 hr. This complex was also seen in cytoplasmic extracts from cells after a 5-min PRL treatment in the same experiment (data not shown). The PRLSF specifically bound to the 32P-labeled IRF-1E. It could be displaced by the addition of excess unlabeled IRF-1E probe (Fig. 1B, lane 2) or an oligonucleotide corresponding to the GRR of the FcyRI gene (Fig. 1B, lane 3) , a sequence similar to the IRF-1E that was required for IFN--induced expression of the FcyRI gene (29) . Unlabeled oligonucleotides corresponding to the ISRE, required for induction of genes by IFN-a (30) , and an oligonucleotide corresponding to the GAS, required for induction of the guanylate binding protein gene by either IFN-a or IFN-y (31), were without effect (Fig. 2B, lanes 4 and 5) . The assembly of all known IFN-activated transcription complexes requires that certain components be tyrosinephosphorylated. Tyrosine phosphorylation of these proteins, including p91, is regulated by membrane-associated IFNactivated tyrosine phosphatase(s) and tyrosine kinase(s) (32) (33) (34) (35) . To determine whether the assembly of PRLSF also depended upon phosphorylated tyrosine residues, we incubated a nuclear extract from PRL-treated cells with recombinant purified phosphotyrosine phosphatase (PTPase) from Yersinia enterocolitica (36) . PTPase treatment of the nuclear extract disrupted the PRLSF complex, but in the presence of the PTPase inhibitor orthovanadate, the complex was unaffected (Fig. 1C, lanes 2 and 3) . The PTPase had no effect on the 32P-labeled oligonucleotide probe (data not shown).
Because p91 binds to the GRR in extracts prepared from IFN--treated cells and cells incubated with a variety ofother cytokines (21, 25, 26) , and the GRR displaced binding of PRLSF from the IRF-1E, experiments were performed to determine whether p91 was a component of the PRLSF complex. Extracts from PRL-treated Nb2 cells or from mouse Ml cells treated with IFN-y were incubated prior to addition of 32P-labeled IRF-1E with anti-p91 antibody prepared against the 39-amino acid C terminus of p91 (25) . (Nb2 cells do not respond to IFN-,y, IFN-a, or EGF under the conditions used for these experiments.) The p91 antibody "supershifted" both the IFN-t-induced complex (Fig. 1D,   lanes 1 vs. 2 ) and the PRLSF (lanes 3 vs. 4), suggesting that both complexes contained p91. An antibody directed against the IFN-a-activated pll3 protein, which is a component of the IFN-stimulated gene ISGF3 transcription complex and is structurally related to p91, did not supershift the PRLSF (data not shown).
To further characterize the tyrosine-phosphorylated protein(s) that were components of the PRLSF, we incubated extracts prepared from untreated or PRL-stimulated Nb2 cells with IRF-lE-agarose beads. The material that bound to the IRF-lE beads was resolved by SDS/PAGE, transferred to Immobilon, and probed with an anti-phosphotyrosine antibody (Fig. 2) . PRL induced tyrosine phosphorylation of a 97-kDa protein that selectively associated with the IRF-1E beads (lanes 1 vs. 2) . A constitutive tyrosine-phosphorylated protein that migrated slightly faster also bound to the affimty beads. Reprobing of the blot with the p91 antibody indicated that the PRL-induced tyrosine-phosphorylated protein was recognized by the antibody (lanes 3 vs. 4) , whereas the constitutive tyrosine-phosphorylated protein was not detected with the antibody. These results not only confirmed those shown in Fig. 1D but also indicated that the p91 that interacted with the IRF-1E was tyrosine-phosphorylated.
It is now evident that a variety of cytokines, including the IFNs, growth hormone, EGF, erythropoietin, IL-3, and those cytokine receptors that utilize the gpl3O siling protein (17, 19, (37) (38) (39) (40) (41) , appear to use the tyrosine kinases of the Jak family as components of their signaling cascade. To determine whether PRL might induce the activation ofany of the known kinases in this family, NB2 cells were incubated with PRL for 15 min prior to immunoprecipitation of solubilized cells with specific antibodies corresponding to either Jakl or Jak2. Immunoprecipitates were resolved by SDS/ PAGE, transferred to Immobilon-P membranes, and probed with an anti-phosphotyrosine antibody (Fig. 3) . PRL treatment of cells caused a selective time-dependent increase in tyrosine phosphorylation of the Jak2 kinase (Fig. 3A , lanes 1 vs. [2] [3] [4] [5] . There was no enhanced tyrosine phosphorylation of either Jakl (Fig. 3B, lanes 1 and 2) or Tyk2 (data not shown). Tyrosine phosphorylation of Jak2 could be detected after a 2-min treatment of cells with PRL and became maximal after Proc. Nat!. Acad. Sci. USA 91 (1994) 7177 15 min of incubation. The anti-phosphotyrosine blots were reprobed with either Jak2 or Jakl antiserum to demonstrate that both Jakl and Jak2 were immunoprecipitated in equal amounts from both untreated cells and cells incubated with PRL ( Fig. 3 A, lanes 6-10, and B, lanes 3 and 4) .
In this report we demonstrate that PRL, which is thought to regulate its effects via tyrosine kinase-activated signaling cascades (3) (4) (5) 42) , can modify proteins by tyrosine phosphorylation so that they bind an enhancer element. This enhancer is present in the promoter of the IRF-1 gene whose transcription is known to be rapidly activated both by IFN-y and PRL (20, 22) . Although it has not yet been determined whether PRL-induced expression of IRF-1 requires the IRF-1E, it has been established that IFN-y-induced expression of this gene requires this element (22) . It therefore seems likely that this element will also be an important component required for PRL-induced IRF-1 expression.
Recent reports have demonstrated that IFN-a-induced phosphorylation of p91 requires the tyrosine kinases Tyk2 and Jakl (33, 41) , IFN-y requires Jakl and Jak2, and growth hormone, erythropoietin, and IL-3 mediate signaling through the related kinase, Jak2 (19, (37) (38) (39) (40) 43) . Since the PRL receptor and the growth hormone receptor are closely related, both activate tyrosine phosphorylation of cellular proteins, and growth hormone enhances Jak2 activity, the observation that PRL also increases tyrosine phosphorylation of Jak2 fits well with the concept of cytokine activation of kinases of the Tyk/Jak family. It is interesting to note that growth hormone treatment of cells also stimulates tyrosine phosphorylation of p91 so that it can bind to the GRR and SIF-E in the c-fos promoter (14, 44) . Although it has been suggested that the Jakl enzyme is required for tyrosine phosphorylation of p91 (38) , the fact that neither growth hormone nor PRL appear to induce tyrosine phosphorylation of Jakl would indicate that at least in certain cases tyrosine phosphorylation of p91 does not correlate with tyrosine phosphorylation of this enzyme. To our knowledge, it is not known whether any enzymes of the Jak family directly phosphorylate p91 or whether another as yet to be defined tyrosine kinase is responsible for this event.
Formation of multimers of phosphorylated proteins is being appreciated as a prevalent mechanism by which transcription factors bind DNA. For example, the ISGF3 transcription complex formed in response to IFN-a treatment of cells contains p91 complexed with p84 and p113 (45) . In addition, recent evidence has suggested that activation of p91 by EGF, IL-10, ciliary neurotrophic factor, growth hormone, IL-6, leukemia inhibitory factor, or oncostatin M also induces tyrosine phosphorylation of another protein that coimmunoprecipitates with p91 but is antigentically distinct (13, 18, 19) . Although no additional phosphotyrosine proteins were immunoprecipitated with p91 after PRL treatment of cells, this does not preclude the possibility that other proteins besides p91 exist in these DNA binding complexes. Alternatively, it has been suggested that p91 alone can bind DNA (8) . The mechanisms by which both PRL and IFN-y can stimulate tyrosine phosphorylation of p91 so that it can bind to the same enhancer yet exert distinct biological actions requires further investigation.
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